Core Viewpoint - The Ministry of Industry and Information Technology has officially announced the seventh batch of national-level specialized and innovative "little giant" enterprises, with Fengshi Technology being the only company from Shandong Province in the marine pharmaceuticals and bioproducts sector to be selected [1]. Group 1: Company Development - Fengshi Technology has achieved a rapid development trajectory, completing a "triple jump" from a specialized small and medium-sized enterprise to a national-level "little giant" in just seven years, which is below the average establishment period for such enterprises [1]. - The company focuses on the deep development and high-value utilization of Antarctic krill, diversifying into multiple "krill+" sectors, including marine technology, biomedicine, and pet technology [4]. Group 2: Industry Trends - The company's strategic focus aligns with national initiatives to develop the marine economy, protect marine ecological environments, and accelerate the construction of a maritime power, as emphasized by the Central Financial Committee [4]. - The biopharmaceutical industry, characterized by high technological content and added value, is a significant representative of emerging industries in China, providing pathways for industrial upgrades and addressing land resource constraints [4]. Group 3: Innovation and Implementation - In 2024, Fengshi Technology plans to launch China's first dual-function krill oil aimed at maintaining healthy blood lipid levels and enhancing immunity, marking a significant step in extending the Antarctic krill industry into the biopharmaceutical field [5]. - The company is set to establish a marine pharmaceutical research and innovation industrial base, focusing on the R&D and industrialization of high-end oral formulations for chronic diseases, metabolic diseases, neurodegenerative diseases, and tumors [5]. Group 4: Ecosystem Development - Fengshi Technology is expanding its ecosystem related to krill, enhancing its development vitality through a robust channel layout, with over 2,100 stores and counters nationwide, and partnerships with major retailers [6]. - The company is also engaging in global collaborations, including partnerships with Norwegian Akva and Italian companies, to enhance the value utilization of Antarctic krill and broaden its industry ecosystem [6].

Core Viewpoint - The company, Fengshi Technology, is leveraging the abundant resources of Antarctic krill to innovate and upgrade its products from functional foods to health supplements, establishing itself as a leader in the industry with a strong focus on technology and innovation [1][4]. Group 1: Company Overview - Fengshi Technology has been recognized with multiple honors, including being named a national intellectual property advantage enterprise and a high-growth marine enterprise in Qingdao, showcasing its strong market position and brand value of 39.199 billion yuan [1]. - The company has invested in a transparent factory covering 18,000 square meters, featuring a GMP purification workshop, ensuring automated and traceable production processes [2]. Group 2: Industry Position and Innovation - The Antarctic krill is recognized as one of the largest biological resources on Earth, with a biomass of hundreds of millions of tons, and is praised for its high nutritional value, including high protein and omega-3 fatty acids [2][5]. - Fengshi Technology has achieved a "5-year 0-defect" quality gold standard from ORIVO, becoming the first and only company to do so, indicating its commitment to quality and international standards [3][5]. - The company has established a three-pronged innovation strategy: one-third from independent research and development, one-third through collaboration with marine research institutions, and one-third from overseas acquisitions [3]. Group 3: Future Directions - Fengshi Technology aims to deepen its research into the medicinal value of Antarctic krill, transitioning from food products to marine biomedicine, thereby enhancing its competitive edge in the market [4]. - The company is focused on integrating marine economy with biomedicine, contributing to the development of a new "blue quality productivity" in the industry [4].